Liberate Medical Announces PREVENT Study with $6.5M Grant Funding from the US DoD – Enrolls First Patients Globally
The PREVENT study is the pivotal clinical trial of the VentFree® Respiratory Muscle Stimulator and will support FDA regulatory clearance of VentFree CRESTWOOD, KY 9 April 2024 – Liberate Medical is proud to announce the successful commencement of patient enrollment... Read More →
Neurotech startup Neurovalens gets FDA clearance for noninvasive anxiety treatment
A 2019 rule change by the U.S. medical devices regulator aimed at encouraging innovations targeting insomnia and anxiety is bearing fruit: Neurovalens, a Belfast-based startup that for over a decade has been developing technology to deliver noninvasive electrical stimulation of the... Read More →
Onkos Surgical Announces First FDA De Novo Approval of an Antibacterial Coating for Tumor and Revision Orthopaedic Implants
Bacterial contamination of orthopaedic implants is a growing clinical challenge that burdens the healthcare system and can lead to dangerous, potentially fatal complications for patients. PARSIPPANY, N.J., April 8, 2024 /PRNewswire/ — Onkos Surgical, an orthopaedic company founded to address... Read More →
Titan Medical Merges with Conavi Medical
Titan Medical Inc. (“Titan”) announced on March 18, 2024, that it is merging with Conavi Medical Inc. (“Conavi”). Titan is a medical technology licensing company based in Toronto with an extensive patent portfolio focusing on robotic assisted surgery. Conavi is a medical device company specializing in... Read More →
Politico Future Pulse Newsletter featuring Limax Biosciences
Researchers envision using the gel to attach medical devices to organs and eventually engineering it to dissolve after the body heals from an injury. They’ve also formed a startup, Limax Biosciences, to commercialize their technology. Read More
Biolinq Raises $58 Million to Advance Wearable Biosensors Through Pivotal Trial for Metabolic Health Using Precision Microsensor Technology
Biosensor platform leverages silicon semiconductor manufacturing for scale. Technology designed to provide a better view of metabolic health by combining glucose information with context around activities of daily living in one device. $58 million in funding led by Alpha Wave... Read More →
Eko Health Gains FDA Clearance For Cardiology Algorithm That Can Detect Heart Failure in 15 Seconds
Eko Health received FDA clearance this week for a new AI-powered tool that aids in the early detection of low ejection fraction, a key indicator of heart failure. About 6.2 million Americans battle heart failure, with many of them experiencing low ejection fraction,... Read More →
FDA authorizes Prenosis software as first AI tool that can diagnose sepsis
The health technology company Prenosis on Wednesday announced its artificial intelligence-powered diagnostic tool for sepsis is the first to receive approval from the U.S. Food and Drug Administration. Sepsis occurs when the body has an extreme response to an infection, and... Read More →
Neurava raises over $2M to advance life-saving epilepsy monitoring device
INDIANAPOLIS, April 3, 2024 /PRNewswire/ — Neurava announced that it has completed and oversubscribed its Series Seed round, raising $2.26 million. Neurava is developing novel and innovative wearable devices for the estimated 3.5 million Americans and 65 million people worldwide... Read More →
Genetesis Announces Formal Publication of Results from the MAGNETO Trial
Results highlight resting MCG as a rapid, radiation-free alternative to standard of care stress testing for diagnosing myocardial ischemia in acute chest pain patients MASON, Ohio, April 02, 2024–(BUSINESS WIRE)–Genetesis, Inc., a leader in the field of magnetocardiography (MCG), today... Read More →